Hetzer and Associates’ 20-line supplier network
supports electronics-enabled medical devices
from concept through production
The global medical device PCB market is projected to grow from $25.23 billion in 2024 to $38.1 billion by 2032 (5.29% CAGR), driven by wearable sensors, implantable therapeutics, and diagnostic imaging systems. All depending on increasingly compact, high-reliability electronics. Building an electronics-enabled device program means coordinating rigid-flex PCB fabrication, precision enclosures, cable assemblies, and full box-build — often from a dozen fragmented vendors, each requiring separate qualification. Hetzer and Associates gives medical device OEMs a single point of contact across the full build, backed by a BOM & Supply Chain Health Analysis service to eliminate sourcing risk as programs move toward design freeze and production scale-up.

The H&A NPI Process for Medical Device Programs
The H&A Advantage
✔ WOSB Certified – eligible for supplier-diversity procurement programs at large medical device OEMs & health systems.
✔ Domestic & International Flexibility – Choose 100% US-based sourcing where your quality system requires it, or blend in international capacity for cost-sensitive programs.
✔ Engineering-Led Electronics Partners – rigid-flex fabrication paired with signal integrity & thermal design support — built for platforms where failure isn’t an option.
✔ Domestic & International Flexibility – Choose 100% US-based sourcing where your quality system requires it, or blend in international capacity for cost-sensitive programs.
Why Hetzer & Associates
WOSB-certified manufacturers’ representative firm with ~30 years of contract manufacturing experience. AS9100D, NADCAP, and CMMC certifications with ITAR registration in place — positioned to support medical device programs alongside our aerospace and defense customer base. The H&A supplier network spans rigid-flex PCB fabrication, precision machining, ISO 13485-certified injection molding, cable harness assembly, and full electronics contract manufacturing — giving medical device OEMs a single point of contact from first-article prototype through full-rate production. Our newest offering, BOM & Supply Chain Health Analysis, gives engineering and procurement teams a clear-eyed audit of sourcing risk — single points of failure, tariff exposure, lead-time risk, and component obsolescence — before it forces a design change and re-qualification cycle.
Partial source: WiseGuy Reports, “Medical Device PCB Market” (2026). Figures reflect global market projections; supplier-specific capacity, certifications, and program details available on request.